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A new pulsed electric field therapy for melanoma disrupts the tumor’s blood
supply and causes complete remission without recurrence
Richard Nuccitelli1,2*, Xinhua Chen1, Andrei G. Pakhomov1, Wallace H. Baldwin1, Saleh Sheikh1,2, Jennifer L. Pomicter1,
Wei Ren1, Christopher Osgood1, R. James Swanson1, Juergen F. Kolb1, Stephen J. Beebe1 and Karl H. Schoenbach1*
1Frank Reidy Research Center for Bioelectrics, Old Dominion University, Norfolk, VA
2BioElectroMed Corp., Burlingame, CA
We have discovered a new, ultrafast therapy for treating skin can-
cer that is extremely effective with a total electric field exposure
time of only 180 lsec. The application of 300 high-voltage (40 kV/
cm), ultrashort (300 nsec) electrical pulses to murine melanomas
in vivo triggers both necrosis and apoptosis, resulting in complete
tumor remission within an average of 47 days in the 17 animals
treated. None of these melanomas recurred during a 4-month
period after the initial melanoma had disappeared. These pulses
generate small, long-lasting, rectifying nanopores in the plasma
membrane of exposed cells, resulting in increased membrane per-
meability to small molecules and ions, as well as an increase in in-
tracellular Ca
21
, DNA fragmentation, disruption of the tumor’s
blood supply and the initiation of apoptosis. Apoptosis was indi-
cated by a 3-fold increase in Bad labeling and a 72% decrease in
Bcl-2 labeling. In addition, microvessel density within the treated
tumors fell by 93%. This new therapy utilizing nanosecond pulsed
electric fields has the advantages of highly localized targeting of
tumor cells and a total exposure time of only 180 lsec. These
pulses penetrate into the interior of every tumor cell and initiate
DNA fragmentation and apoptosis while at the same time reducing
blood flow to the tumor. This new physical tumor therapy is drug
free, highly localized, uses low energy, has no significant side
effects and results in very little scarring.
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The most common treatment for skin cancer is the surgical
removal of the lesion. This is time consuming and almost always
leaves a scar. An alternative approach is electrochemotherapy in
which the tumor is exposed to a toxic drug after electropermeabili-
zation1 using electric pulses in the microsecond domain. A third
approach is irreversible electroporation that kills the treated tissue
by necrosis resulting from permanent permeabilization using
microsecond domain pulses with larger amplitudes.2 We have dis-
covered that if the electric pulses are shortened 1,000-fold into the
nanosecond domain, they are able to independently initiate the
process of apoptosis within the tumor cells themselves, causing
the tumor to slowly self-destruct without requiring toxic drugs or
permanent permeabilization.3 In addition to initiating apoptosis in
the tumor cells, nanosecond pulsed electric fields (nsPEFs) halt
blood flow in the capillaries feeding it. This reduced blood flow to
the tumor and activation of apoptosis pathways cause the tumor to
slowly shrink and disappear within an average of 47 days. This
treatment exposure time is only 180 lsec, but we paused 2 sec
between pulses to be sure that there would be no significant tem-
perature increase. This resulted in a total treatment time of 10 min
and resulted in little or no scarring.
The two main reasons that these nanosecond pulses are so effec-
tive is that (i) they are fast enough to penetrate into the cell and all
organelles; and (ii) they are short enough that an electric field
strength large enough to cause small pore formation in membranes
can be used without significant heating. As long as the pulse rise
time is faster than the characteristic cellular membrane charging
time of about 0.1–1 lsec, the interior charges will not have suffi-
cient time to redistribute to counteract the imposed field and it
will penetrate into the cell and charge every organelle membrane
for a duration, which is dependent on both the charging time con-
stant of the cell’s plasma membrane as well as that of the organ-
elle membrane. Pulses 300 ns long are near the upper limit of this
penetrating range and have the advantage of delivering an effec-
tive energy dose (0.2 J) without significantly heating the tumor.4
Material and methods
Pulsed electric field application
The generation of unipolar, high-voltage pulses with a duration
between 100 and 600 nsec was based on the concept of transmis-
sion lines and pulse-forming lines as described in detail recently.5
A matching resistor equal to the pulse generator impedance was
placed in parallel with the load so that the total impedance would
be to assure the delivery of a single well-defined trapezoidal pulse
across the biological sample. We used 4 different configurations
providing similar exposures in the experiments reported here: (i)
all of the animal studies were conducted with a pulse-forming
network with an impedance of 75 X. It consists of 30 pairs of
high-voltage capacitors and 30 inductors arranged in a Blumlein
configuration, and generates a 300-nsec long high-voltage pulse
with a 30-ns rise time.4,5 The closing switch consisted of a mer-
cury displacement relay that was controlled by a microcontroller.
The voltage across the object was monitored using a high-voltage
probe (P6015A, Tektronix, Beaverton, CA), and the current was
measured by means of a Pearson coil (model 2877, Pearson Elec-
tronics, Palo Alto, CA). Current and voltage were recorded simul-
taneously using a digitizing oscilloscope (TDS3052, Tektronix,
Beaverton, OR). The electric field pulses were applied by lifting
the skin containing each tumor away from the mouse between 2
fingers and gently placing the tumor between 2 polished parallel
circular stainless steel electrodes on the end of a clothespin-shaped
applicator. The electrodes were 5 mm in diameter and completely
covered each tumor with a 1-mm space between the electrodes.
The tumors sometimes slipped away from this region while being
squeezed between the plates, so pulses were usually applied in 3
groups of 100, at a frequency of 0.5 Hz and the electrodes were
repositioned between each group of pulses to ensure that the entire
tumor was being exposed to the field. (ii) For the intracellular
Ca21 studies, we used a 100 X Blumlein line coaxial cable pulse
generator with a MOSFET closing switch (DE275-102N06A,
IXYS, Milpitas, CA). The switch was triggered by a MOSFET
driver (DEIC420, IXYS) which was, in turn, controlled by a 12-bit
microprocessor (Analog Devices ADuC 841 Microconverter1).
This pulse generator exhibited a rise time of 7 nsec and pulse du-
ration of 100 nsec. (iii) For the comet studies, cells were placed in
a cuvette with aluminum electrodes on 2 opposing inner walls and
we used a 10 X transmission line pulse generator with a gap dis-
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tance-adjusted self-breakdown spark gap as a closing switch. This
pulse generator exhibited a rise time of 5 nsec and pulse duration of
300 nsec. (iv) For the patch-clamp experiments we used a 50 X
transmission line circuit with a MOSFET closing switch (DE275-
102N06A). The pulse generator delivers a 600-nsec pulse with a
rise time of 4 nsec to a pair of tungsten wire electrodes. The wire di-
ameter was 0.1 mm and the gap between them was 0.11 and 0.12
mm. For convenience, the pulse generator was triggered by external
TTL pulses using pClamp software and the Digidata board.
Cell culture
Mammalian cell lines used in this study were obtained from
American Type Culture Collection (Manassas, VA). Murine mela-
FIGURE 1.
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noma (B16-F10) cells were grown in Dulbecco’s Modified Eagle’s
Medium (ATCC Catalog No. 30-2002) supplemented with 10%
fetal bovine serum (Atlanta Biologicals S11550, Norcross, GA),
2% L-glutamine, 100 IU/ml penicillin, 100 lg/ml streptomycin
and 0.25 lg/ml amphotericin B (Cellgro/Mediatech 25-005-CI
and 30-001-CI) in a 75 cm2 culture flask maintained at 37C with
5% CO2 in air by a water-jacketed cell culture incubator. Cells
used were between passages 7 and 19, and never allowed to reach
FIGURE 1 – Tumor responses to nsPEF. (a) Transillumination and surface views of a melanoma in mouse 219 that responded with complete
remission after a single treatment of 300 pulses (40 kV/cm, 300 nsec) on day 0. The asterisk indicates the day on which nsPEF was applied and
the adjacent photos were taken shortly after nsPEF treatment. The cultured melanoma cells were injected beneath the skin 3 days before this
image was taken and angiogenesis is already evident. The capillaries near the tumor begin to breakdown after nsPEF treatment. For comparison,
1 of the untreated control tumors is shown below. The 2-mm bar in the top images applies to all frames below them. (b) Mouse 180 is typical of
10 melanomas that exhibited total remission of the tumor after 2 nsPEF treatments. Melanoma shrinkage is documented by transillumination
and reflected light photomicroscopy after treatments of 600 pulses (40 kV/cm, 300 ns) on day 0 and 300 pulses on day 14. The tumor did not
recur through day 169 when mouse 180 was euthanized. Each pair of images was taken on the day after nsPEF treatment indicated by the num-
bers on the left. The image pairs on day 0 were taken before (0) and after (0*) 300 pulses of 40 kV/cm, 300 nsec. The tumor did not recur
through day 169 when mouse 180 was euthanized. (c) Mouse 205 is typical of 3 mice that exhibited total remission of the tumor after 3 nsPEF
treatments. Melanoma shrinkage is documented by transillumination and reflected light photomicroscopy after treatments of 300 pulses (40 kV/
cm, 300 nsec) on days 0, 18 and 31. Each pair of images was taken on the day indicated by the far left column. No recurrence of the tumor
occurred through day 158 when mouse 205 was euthanized. The asterisk indicates the days on which nsPEF was applied. (d) Survival curve for
17 nsPEF-treated mice and 18 untreated controls with 1 melanoma each. All 17 treated mice exhibited complete tumor remission without recur-
rence during 150 days before euthanizing. One of these mice was euthanized on day 130 because of a 20% weight loss in a week but did not
exhibit metastasis to the lungs or liver. A second treated mouse was euthanized on day 144 because of an eye infection. Controls were
euthanized when tumors ulcerated.
FIGURE 2 – Photomicrographs of 3 melanomas taken on the day indicated for each column after nsPEF treatment. Rows are grouped in
matched pairs with the top image of the pair being the surface view and the bottom image being the transillumination view of the tumor. All
images were taken at the same magnification indicated by the scale bar in the upper left image. The animal number is shown to the left of each
grouped pair. Mouse 183 and 181 were treated on day 0 with 600 pulses (45 kV/cm, 300 nsec long) and again on day 18 with 300 pulses. Mouse
204 was only treated once on day 0 with 300 pulses (40 kV/cm, 90 A, 300 nsec) and the tumor exhibited total remission following this single
treatment. The scale bar in the upper left photo applies to all of these images. Red tattoo marks were used to indicate the original tumor location.
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greater than 75% confluency. Patch-clamp experiments used a
murine pituitary cell line, GH3, cultured in Ham’s F12K medium
supplemented with 2.5% fetal bovine serum and 15% horse serum
(Atlanta Biologicals).
Animals
Female SKH-1 hairless mice were injected beneath the skin at 1
location on the back with 106 B16-F10 cells using a protocol
approved by the Eastern Virginia Medical School IACUC. If these
tumors became ulcerated, the mouse was euthanized. In the
nsPEF-treated group, 13 mice were 3 months old when injected
with melanoma cells and 4 mice were 2 months old. In the control
group, 4 were 4 months old, 10 were 3 months old and 4 were 2
months old when injected with melanoma cells
Patch-clamp setup and data acquisition
Pipettes for patch-clamp recording were manufactured from
borosilicate glass (1B150F-4, World Precision Instruments, Sara-
sota, FL, or BF150-86-10, Sutter Instrument, Novato, CA). They
were pulled to a tip resistance of 1.5–3 MX using a Flaming/
Brown P-97 Micropipette puller (Sutter).
Exposures of individual cells to nsPEF and subsequent meas-
urements of membrane resistance (Rm) were performed in a glass-
bottomed chamber (Warner Instruments, Hamden, CT) mounted
to the stage of an inverted microscope. The microscope was an
Olympus IX71 (Olympus America, Center Valley, PA). A cover-
slip with cells was placed into the chamber filled with a bath
buffer at room temperature, and an individual cell suitable for
nsPEF exposure and patch-clamp recording was selected. The
nsPEF-delivering electrodes and a glass micropipette were posi-
tioned next to the selected cell using MP-285 and MP-225 robotic
micromanipulators (Sutter Instrument, Novato, CA).
Electrophysiology data were acquired using a Multiclamp 700B
amplifier, Digidata 1322A or 1440A A-D converter, and
pCLAMP10 software (MDS, Foster City, CA).
Intracellular Ca21 measurement
B16 cells were loaded with 5 lM Fluo-4 AM in Hank’s Buffered
Salt Solution supplemented with 6.7 mM HEPES buffer and 2.5
mM glucose for 45 min in the dark at room temperature. Loading
was performed at room temperature to minimize dye compartmen-
talization.6,7 Extracellular Ca21 was chelated by the addition of 5
mM EGTA to the buffer before applying nsPEFs. A glass coverslip
electrode chamber was constructed for applying the nsPEF to the
cells. The chamber was fabricated by first metalizing a No.1 cover-
slip glass by thermal evaporation of chromium and nickel, then pat-
terning a 30-lm thick positive photoresist electroplating mold, and
finally electrodeposition from a nickel sulfamate plating bath with
a gold top coat to ensure biological compatibility. This process
yields electrodes that are deposited directly onto the glass substrate
with no intermediate glue layer. The electrode gap distance is 100
lm, allowing the application of electric fields of up to 100 kV/cm
with a Blumlein line pulse generator charged to 1 kV. Five microli-
ters of cells in phosphate-buffered saline (PBS) were placed into
the electrode gap and covered with an 8-mm round coverslip.
Experiments were performed at 37C using a custom-made micro-
scope objective heater. Confocal imaging was performed with a
Perkin Elmer UltraVIEW spinning disk confocal imager mounted
on an Olympus IX71 inverted microscope with a 603 oil immer-
sion objective (numerical aperture of 1.42). To prevent evapora-
tion, the round coverslip was sealed with pure silicone fluid
(Clearco Products, Bensalem, PA) dispensed from a large plastic
syringe with a luer stub anchored with epoxy. The electric pulses
(40 kV/cm 100 nsec) were delivered by a MOSFET-triggered
Blumlein coaxial cable pulse generator attached to 25-lm thick
electrodes initially vacuum deposited and then electroplated onto a
glass coverslip while maintaining a 100-lm gap between the 2 par-
allel electrodes (BioElectroMed Corp., Burlingame, CA).
Immunocytochemistry
Tumors were fixed in 10% buffered formalin overnight and
processed for histology. Serial tissue sections were deparaffinized
and antigen retrieval was achieved by microwaving for 10 min in
0.01 M citrate buffer (pH 6.0). The following antibodies were
used to label the slides: Bcl-2(C-2), Bad(H-168) (Santa Cruz Bio-
technology, Santa Cruz, CA) Microvessel density was identified
by incubating sections for 1 hr with anti-mouse CD31 antibody
(M-20; Santa Cruz Biotechnology). Tissue microarrays were
adopted for homogeneity and high-throughput analysis. One sec-
tion was stained with hematoxylin–eosin (H&E) for histopatho-
logical diagnosis before immunocytochemistry. The percentage of
each section stained with 1 of these antibodies was determined by
using Photoshop’s Magic Wand to cut out the labeled region of
each slide and Image J was then used to determine the percentage
of each section covered by the label.
DNA fragmentation assay
B16-F10 mouse melanoma cells, passage numbers 5–15, were
collected and washed in PBS. One hundred forty microliters of
cells (1 3 105 cells/ml) were placed in disposable cuvettes with
parallel plate, aluminum electrodes on 2 sides (Biosmith Biotech,
1 mm gap) and pulsed using parameters similar to those used for
in vivo experiments described above (typically, 300 nsec pulse
FIGURE 3 – Lack of propidium iodide (PI) uptake after nsPEF expo-
sure. GH3 cells were exposed to 2 Hz train of ten 600-nsec pulses at
4.2 kV/cm in the medium containing 20 lg/ml PI (other components,
mM: 135 NaCl, 5 KCl, 2 MgCl2, 10 HEPES and 10 glucose). The
images were captured immediately before (a) and 300 sec after the
exposure (b). Right panel: PI fluorescence channel. Left panel: PI fluo-
rescence overlaid with a DIC image. Exposure caused minor morpho-
logical changes (swelling, blebbing, granulation), but no PI uptake. (c)
Positive control: same cells 20 sec after membrane permeabilization
by addition of digitonin (0.1%). Calibration bar: 10 lm. Note that this
nsPEF exposure was far more intense than required for a profound
effect on the electrical conductance of plasma membrane (e.g., Fig.
3d). This result was consistently observed in more than 6 experiments.
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duration, 40 kV/cm, pulse numbers 10–100). Control cells were
pipetted into cuvettes, and held under identical conditions to those
cells subjected to nsPEFs. After pulsing, 10-ll aliquots of cells
were withdrawn and mixed with 100 ll of 2% low-melting agarose
in PBS (Amresco, Agarose II) at 30C. Seventy-five microliters of
the cell mixture was spread onto glass slides and allowed to gel at
room temperature. The slides were then processed essentially as
described in Refs. 8 and 9. Slides were immersed in chilled lysis
buffer (1.24 mM NaCl, 200 mM EDTA, 10 mM Tris–HCl, 34 mM
sarkosyl, 10 mM Triton-X 100, pH 10.0) for 1 hr. The slides were
then placed in a horizontal electrophoresis chamber, submerged in
alkaline electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH
> 13) and held at room temperature for 30 min. They were then
exposed to 2.5 V/cm for 30 min at room temperature. The slides
were rinsed twice in excess neutralization buffer (0.4 M Tris–HCl,
pH 7.5), briefly rinsed with water, and then stained with propidium
iodide (210 lg/ml). Cells were imaged with an Olympus DP70
digital camera using fluorescent microscopy with a mercury lamp
and TRITC filter set (exciter filter: 510–550 nm; 570nm dichroic;
barrier: 590 longpass). Images were analyzed for comet quantifica-
tion using CometScore software (TriTek Corp).
Results
We generated 1 melanoma in each of 35 SKH-1 albino, hairless,
immune-competent mice by injecting 106 murine B16-F10 cells
just under the skin on the back of each animal. Within 3 days,
these cells formed a melanoma with a discoid shape 3–4 mm in di-
ameter and about 1-mm thick that exhibited angiogenesis. These
melanomas can be best observed in albino mice because their skin
is translucent. When the skin containing the tumor is stretched
over a light source, the pigmented tumor and blood supply are
very clear. Digital images of the tumor using this transillumination
technique with a stereoscope provide a very accurate assessment
of tumor size and blood supply (Fig. 1a; day 0). Eighteen of these
tumors served as controls and were not treated (Fig. 1a). Their
continued growth caused 39% to become ulcerated within 16–21
days, at which time those mice were euthanized. The survival
curve for the controls (Fig. 1d) indicates when each had to be
euthanized and only 3/18 were still alive 6 months after melanoma
cell injection. The melanomas had stopped growing in these 3
controls but residual melanin was still present.
We treated 17 of the melanomas with 1–3 applications of either
300 or 600 electric pulses (40–50 kV/cm, 70–90 A, 300 nsec, 0.5
Hz). We demonstrated previously that this treatment of only 90–
180 lsec of total field exposure time does not heat the tumor more
than 3C but is sufficient to cause the tumor to shrink by 90%
within 2 weeks.4 Our goal here was to determine if these melano-
mas could be completely eliminated, without recurrence, using
only 1–3 nsPEF treatments.
Twenty-four percent of the melanomas exhibited complete
remission with a single nsPEF treatment
Mouse 219’s melanoma was 1 of the 4 melanomas that
responded to a single nsPEF treatment with complete remission
(Fig. 1a). For each indicated day after treatment, both the transil-
lumination and the reflected light images are shown. Note that the
capillaries feeding the tumor begin to breakdown after treatment
(0*) and are completely gone by day 6. By day 29, the tumor was
also essentially gone and did not recur over the 144 days that we
followed it before euthanizing the animal. We observed a similar
time course for the other 3 animals whose tumors disappeared
after a single nsPEF treatment.
Fifty-nine percent of the melanomas exhibited complete
remission with 2 nsPEF treatments
We photographed each tumor every 2 to 3 days to determine if
it was beginning to grow again. Once we detected regrowth, we
treated the tumor with 300 more pulses using the same parameters
as described above. Mouse 180’s melanoma (Fig. 1b) is typical of
10 of the 17 tumors that responded to 2 nsPEF treatments with
complete remission. Comparing the melanoma size on days 11
and 13 suggested possible regrowth, which was even clearer on
day 14, so we treated the tumor again on that day. Two weeks
FIGURE 4 – Changes in the electrical conductance of the plasma membrane resulting from a 600-nsec electric pulse. (a) Whole-cell currents
in a GH3 cell elicited by voltage steps from 2100 to 1100 mV (shown in c) 20 sec before nsPEF exposure. Patch pipette was filled with the
extracellular solution containing (mM) 140 Cs-acetate, 5 Cs-EGTA, 4 MgCl2 and 10 HEPES. (b) Recording from the same cell 10 sec after a
single 600 nsec pulse at 2.4 kV/cm. The orientation of the applied nsPEF was perpendicular to the axis of the patch electrode so that the elec-
trode would not interfere with the electric field’s effect on the cell. (d). Current–voltage curves corresponding to A and B. Note profound
increase of the mean inward current and ‘‘noise’’ at negative transmembrane voltages and lack of changes at positive voltages. Exposed cells
could recover completely, but the process typically took several minutes (data not shown).
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later, the tumor was barely visible and no recurrence could be
detected by day 169 when we euthanized the animal. A small re-
sidual pigment spot could be detected in some of the animals, but
it did not change over months of observation, and histological
analysis confirmed that no tumor cells were present.
Eighteen percent of the melanomas required 3 nsPEF
treatments for complete remission
Three of the 17 melanomas began growing again after 2 treat-
ments so a third nsPEF treatment was administered to those
(M205, Fig. 1c). All of these melanomas exhibited complete
remission after the third nsPEF treatment and did not recur.
Figure 1 illustrates the changes in melanoma size during the
nsPEF treatment times. We also present a more complete photo-
graphic record for 3 other nsPEF-treated melanomas in Figure 2.
All of the nsPEF-treated melanomas shrink in surface area by 90%
on average within 2 weeks.
How do these pulses trigger the self-destruction of
melanoma tumors?
We have identified several cellular targets affected by these
ultrashort electric pulses including tumor blood flow, membrane
conductance, intracellular Ca21, DNA fragmentation, microvessel
disruption and the initiation of apoptosis.
nsPEF application rapidly reduces blood flow to the tumor
Transillumination images clearly show that the blood vessels
feeding these tumors before pulsing disappear within a day after
pulsing (Figs. 1 and 2). This disruption of blood flow to the tumor
stresses these rapidly dividing cells and many exhibit necrosis.
The remainder of the tumor cells exhibit apoptosis as shown
below. There is also a reduction in microvessels in the tumor as
discussed below (Figs. 7e and 7f).
nsPEF application changes membrane conductance
We used whole cell patch clamp to measure plasma membrane
conductance changes in a murine pituitary cell line, GH3, result-
ing from nanosecond pulsed electric field exposure and have
detected unique ‘‘nanopores’’ generated in the plasma membrane
after nsPEF exposure. We call them nanopores because mem-
brane-impermeant dyes, such as trypan blue or propidium iodide,
do not pass through them in contrast to the pores generated by
classical electroporation (Figs. 3b and 3c). Surprisingly, this
increase is not due to the formation of a nonspecific pore in the
membrane. If these nanopores were simply holes, their I-V charac-
teristic would be a straight line, linear at any voltage and crossing
the abscissa at or near 0 mV. The actual conductance is very dif-
ferent. There is a good deal of inward current at negative poten-
tials, but no positive (outward) current at positive potentials (Fig.
4d). So, the nanopores exhibit inward rectification along with inhi-
bition of voltage-gated outward K1 current at positive membrane
potentials. These behaviors clearly distinguish the permeability
increase resulting from nsPEF application from that resulting from
the application of much longer pulses used for classical electropo-
ration. Two other important characteristics of the nsPEF-induced
permeability increase are that it is long lasting, and it increases
with field strength. Whole cell membrane conductance measured
2–3 min after exposure to a single pulse of 2.4 or 4.8 kV/cm
exceeded the control values 4–5-fold and about 10-fold, respec-
FIGURE 6 – DNA fragmentation is evident after nsPEF application
using the Comet assay with B16 cells in vitro. (a) After the application
of 40 kV/cm pulses 300 nsec long using the number of pulses indi-
cated in the upper left corner of each frame, DNA fragmentation
occurs as indicated by the comet tails in the figure. (b) Quantification
of propidium iodide fluorescence allows us to estimate the percentage
of total DNA in the comet tail. When plotted against the square root
of pulse number, a linear dependence is revealed that predicts 100%
DNA fragmentation when cells are exposed to 100 pulses. The straight
line is a least squares fit to the 4 data points and the error bars repre-
sent the S.E.M. with the number of cells averaged for each point
printed next to it.
FIGURE 5 – Average intracellular Ca21 changes in 10–20 B16-F10
cells loaded with Fluo-4AM when pulsed at the times marked by the
arrows (40 kV/cm, 100 nsec) at 37C. Top curve represents the aver-
age Ca21 increase in normal medium, middle curve represents the
average intracellular Ca21 increase in Ca21-free medium (5 mM
EGTA) and the lowest curve represents the average cellular fluores-
cence when no pulses were applied. Instead of plotting all of the
SEMs, only the largest S.E.M. in each region of the curve is plotted.
Inset figure shows the Ca21 change in 1 cell triggered by a single 100-
nsec pulse of 40 kV/cm in Ca21-free medium.
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tively. These lower pulse amplitudes were chosen because they
generated nanopores without electronic disturbance to the patch-
clamp computer.
nsPEF application triggers increases in intracellular Ca21
We imaged the intracellular Ca21 changes in cultured B16-F10
cells loaded with Fluo-4AM in response to nsPEF on a spinning
disk confocal microscope (PerkinElmer Ultraview, Waltham,
Massachusetts). Intracellular Ca21 increased immediately after
nsPEF application because of both release from intracellular stores
and Ca21 influx through the plasma membrane. By chelating
extracellular Ca21 with 5 mM EGTA, we determined that 45% of
the total Ca21 change is due to release from intracellular stores
(Fig. 5). Cells recovered from this increased Ca21 within 90 sec at
37C (inset, Fig. 5). We averaged the fluorescence signal from 10
to 20 cells taken from multiple fields of view and on different
days to obtain the data illustrated in Figure 5. Because our mela-
noma tumor treatment exposed the tumor cells to 1 pulse every 2
sec, intracellular Ca21 would have been elevated for 10 min dur-
ing a 300-pulse exposure.
nsPEF application triggers DNA fragmentation
Because pyknosis of tumor cell nuclei was evident in histologi-
cal sections of fixed tumors as soon as 10 min after nsPEF expo-
sure,4 we used the comet assay to examine DNA fragmentation.
We found that fragmentation occurs very rapidly after nsPEF
application and the degree of fragmentation increases with pulse
number (Fig. 6). We have observed this fragmentation in response
to nsPEF of different pulse widths (60, 100 and 300 nsec) and
observed some DNA repair if we delayed permeabilization of the
cells for the comet assay for an hour (data not shown). We find
that the degree of DNA fragmentation in vitro is linearly propor-
tional to the square root of the pulse number Figure 6b. This may
be related to our observation that 1 and 10 pulses have little effect
on the tumors but 100 pulses strongly triggers apoptosis.4
nsPEF application triggers apoptosis in vivo
Bcl-2 is a family of proteins involved in the response to apopto-
sis. Some of these proteins (such as Bcl-2 and Bcl-XL) are antia-
poptotic, whereas others (such as Bad, Bax or Bid) are proapop-
totic. The sensitivity of cells to apoptotic stimuli can depend on
the balance of pro- and antiapoptotic Bcl-2 proteins. We investi-
gated the involvement of Bcl-2 and Bad using immunohistochem-
istry on sections from both nsPEF-treated and untreated tumors.
We observed an average decrease of 74% in the antiapoptotic Bcl-
2 labeling when comparing 9 nsPEF-treated tumors to 9 untreated
tumors (Fig. 7). In contrast, the apoptotic label, Bad, increased by
an average of 320% (n 5 8 treated and 8 untreated). Both of these
changes suggest that nsPEF initiates apoptosis in the tumor cells
in vivo.
nsPEF application changes microvessel density
Tumor growth depends on a local increase in vasculature, which
requires the formation of new capillaries in a process known as
angiogenesis. Endothelial cells forming capillaries can be detected
with antibodies to the endothelial cell marker, CD31.10 We
reported previously that nsPEF disrupts blood flow to larger mela-
nomas based on power Doppler data from high-resolution ultra-
sound, but that technique cannot detect microvessels.4 Here, we
used immunocytochemistry to detect endothelial cell density in
both nsPEF-treated and untreated sections from 5 different mela-
nomas and found an average reduction of 92% in CD31 expression
in nsPEF-treated tumors (Figs. 7e and 7f). This suggests that the
microcirculation to the treated tumors is severely reduced and this
should lead to necrosis and tumor shrinkage.
Discussion
The use of nsPEF to eliminate skin tumors is a new approach
that has several major advantages over conventional therapies. It
is very fast, 100% effective, and causes minimal skin scarring by
initiating apoptosis pathways in which the tumor slowly self-
destructs. Two other therapies that have used electric fields are
electrochemotherapy and irreversible electroporation. The former
FIGURE 7 – Immunocytochemistry of control and nsPEF-treated tumors (300 pulses, 40 kV/cm) using antibodies to Bcl-2, Bad and CD31.
(a) Control tumor labeled with antibodies to Bcl-2; (b) nsPEF-treated tumor labeled antibodies to Bcl-2 1 week after nsPEF treatment; (c) control
tumor labeled with antibodies to Bad; (d) nsPEF-treated tumor labeled with antibodies to Bad 1 week after nsPEF treatment; (e) control tumor
labeled with anti-endothelial cell antigen (CD31); and (f) nsPEF-treated tumor labeled with antibodies to CD31one week after nsPEF treatment.
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allows the introduction of toxic drugs to the tumor by electro-
poration and the latter uses much longer pulses (100 lsec) of
2.5 kV/cm amplitude to permeabilize cells irreversibly to cause
necrosis.2,11 Both of these approaches are fundamentally different
from the use of nsPEF. Although nsPEF does cause some necrosis
by sharply reducing the blood supply to the tumor, much of the
self-destruction involves apoptosis resulting in tumor resorption
over an average of 47 days. This much slower elimination of the
tumor results in less scar formation and no recurrence of the tu-
mor, which is a major advantage over irreversible electroporation,
which kills by necrosis alone.
Another therapy that uses electric fields, typically in the radio
frequency band, is hyperthermia. This approach kills the tumor by
heating it to temperatures greater than 42C for several minutes.
Because tissues conduct heat quite well, it is impossible to exclu-
sively heat the tumor without heat transfer to tissues that are in
contact with it. One distinct advantage of nsPEF over hyperther-
mia is the ability to more sharply localize target tissues because
only cells located between the electrodes are exposed to the
nsPEF. An additional advantage is the much shorter treatment
time for nsPEF. Although we used a 10-min treatment time
(0.5 Hz) to be certain that we would not heat the tumor more than
3C as documented in our previous article,4 the tumor temperature
increase levels off after the initial 2 min of pulse application.
Therefore, it is likely that higher pulse application frequencies
could be used without significant temperature increases and that
could substantially shorten the total treatment time.
How does nsPEF treatment lead to apoptosis and DNA frag-
mentation? Several previous studies of cells in vitro have provided
very strong evidence that nsPEF application triggers apoptosis12,13
and increases in intracellular Ca2114–18 in Jurkat, HL-60 and chro-
maffin cells. These previous studies were all conducted at room
temperature, whereas those reported here were conducted at 37C.
At room temperature, we would predict that the recovery from the
Ca21 increase would be slower because of the slower kinetics of
the Ca21 pumps. That seems to be the case for HL-60 and Jurkat
cells, but chromaffin cells actually recover faster.17 Another inter-
esting characteristic of chromaffin cells is that most of the Ca21
enters from the outside rather than from the internal stores.
NsPEF application to melanomas in vivo also triggers apoptosis
and (Fig. 7) but in addition has other effects, such as the reduction
in blood flow to the tumor and the increase in intracellular Ca21.
Both of these latter changes are important signals for initiating
tumor cell death. If intracellular Ca21 remains high for several
minutes, it can initiate several metabolic cascades that will lead to
cell death and DNA fragmentation.19,20 The formation of nano-
pores leads to an increase in intracellular Ca21, and both the elec-
tric field strength and pulse number influence this permeability
increase. The larger the pulse number and the electric field, the
larger will be the permeability increase in the plasma mem-
brane21–23 that will lead to a long-lasting increase in intracellular
Ca21.
This nsPEF therapy has also been used to treat skin tumors by
another group at the University of Southern California.24 They
have found it effective against pancreatic tumors developing from
cells injected beneath mouse skin as well as for a single case of a
human basal cell carcinoma that exhibited complete remission af-
ter 1 treatment with nsPEF with very little scarring (200 pulses, 20
nsec long, 43 kV/cm). This suggests that this new therapy, which
has proven very effective for treating mouse skin cancer, might be
equally as effective on humans.
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